Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis

The decision for definitive therapy for the treatment of patients with connective tissue disease-associated interstitial lung disease (CTD-ILD) is difficult. Patients with CTD-ILD received 0.5 g twice a day of mycophenolate mofetil for 2 years (MMF cohort, n = 105) or cyclophosphamide 50 mg once eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Pengfei, Zhang, Li, Guo, Qian, Zhao, Lifen, Hao, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656757/
https://www.ncbi.nlm.nih.gov/pubmed/38025531
http://dx.doi.org/10.1515/med-2023-0838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656757/
https://www.ncbi.nlm.nih.gov/pubmed/38025531
http://dx.doi.org/10.1515/med-2023-0838

Ejemplares similares